Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CryoPort Inc (CYRX)
NASDAQ:CYRX
CryoPort (CYRX) Stock Price & Analysis
541 Followers
CYRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.00 - $24.17
Previous Close$16.11
Volume296.91K
Average Volume (3M)448.16K
Market Cap
$789.03M
Enterprise Value$748.28M
Total Cash (Recent Filing)$456.75M
Total Debt (Recent Filing)$416.00M
Price to Earnings (P/E)-7.3
Beta2.49
Next Earnings
May 02, 2024EPS Estimate
-$0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.20
Shares Outstanding48,977,476
10 Day Avg. Volume387,025
30 Day Avg. Volume448,157
Standard Deviation0.20
R-Squared0.18
Alpha0.00525
Financial Highlights & Ratios
Price to Book (P/B)4.92
Price to Sales (P/S)3.38
Price to Cash Flow (P/CF)79.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.21
Enterprise Value/Gross Profit4.13
Enterprise Value/Ebitda-12.03
Forecast
1Y Price Target
$18.00Price Target Upside11.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
CryoPort News
PremiumCompany Announcements
CryoPort Inc Strengthens Leadership and Updates Executive Agreements
Bulls Say, Bears Say
Bulls Say
Company GrowthAssuming commercial biopharma revenues continue to grow, the guidance may prove conservative, presenting an opportunity for future financial performance surprises.
Market PositionCYRX's role as a leading player in cryogenic logistics, backed by a solid revenue stream from supported therapies and a robust clinical trial pipeline, positions it well for sustained growth.
Strategic FocusThe company's ongoing investment in growth drivers showcases its commitment to long-term expansion and innovation in its product offerings.
Bears Say
Financial Guidance2024 revenue guidance of $242-252M was shy of expectations, setting a more conservative outlook after previous overestimation.
Operational ConcernsConcerns around operational expenditure growth outpacing revenue increases could signal inefficiencies within the company's operations.
ProfitabilityGross margins of 40.6% showed contraction, hitting the lowest level in roughly seven years, affected by changing product mix.
---
Ownership Overview
3.30% Insiders
33.84% Mutual Funds
15.53% Other Institutional Investors
47.34% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CYRX FAQ
What was CryoPort Inc’s price range in the past 12 months?
CryoPort Inc lowest stock price was $9.00 and its highest was $24.17 in the past 12 months.
What is CryoPort Inc’s market cap?
Currently, no data Available
When is CryoPort Inc’s upcoming earnings report date?
CryoPort Inc’s upcoming earnings report date is May 02, 2024 which is in 7 days.
How were CryoPort Inc’s earnings last quarter?
CryoPort Inc released its earnings results on Mar 12, 2024. The company reported -$1.31 earnings per share for the quarter, missing the consensus estimate of -$0.283 by -$1.027.
Is CryoPort Inc overvalued?
According to Wall Street analysts CryoPort Inc’s price is currently Undervalued.
Does CryoPort Inc pay dividends?
CryoPort Inc does not currently pay dividends.
What is CryoPort Inc’s EPS estimate?
CryoPort Inc’s EPS estimate is -$0.33.
How many shares outstanding does CryoPort Inc have?
CryoPort Inc has 48,977,474 shares outstanding.
What happened to CryoPort Inc’s price movement after its last earnings report?
CryoPort Inc reported an EPS of -$1.31 in its last earnings report, missing expectations of -$0.283. Following the earnings report the stock price went down -11.902%.
Which hedge fund is a major shareholder of CryoPort Inc?
Among the largest hedge funds holding CryoPort Inc’s share is Blackstone Inc.. It holds CryoPort Inc’s shares valued at 7M.
---
CryoPort Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.00 (11.73% Upside)
$18.00 (11.73% Upside)
Blogger Sentiment
Bullish
CYRX Sentiment 66%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth $132.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.27%
12-Months-Change
Fundamentals
Return on Equity
-19.06%
Trailing 12-Months
Asset Growth
-8.49%
Trailing 12-Months
Company Description
CryoPort Inc
CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.
---
CYRX Earnings Call
Q4 2024
0:00 / 0:00
---
CYRX Stock 12 Months Forecast
Average Price Target
$18.00
▲(11.73% Upside)
Technical Analysis
Best Analysts Covering CYRX
1 Year
1 Year Success Rate
4/16 ratings generated profit
1 Year Average Return
-24.18%
reiterated a buy rating last month
Copying David Larsen's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -24.18% per trade.
---